rabeprazole has been researched along with Cardiovascular Diseases in 5 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to clarify the efficacy of rabeprazole for preventing peptic ulcer, esophagitis, and gastrointestinal symptoms associated with LDA." | 9.16 | Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. ( Azuma, T; Fujisawa, T; Fujita, T; Hayakumo, T; Inokuchi, H; Kawai, T; Kutsumi, H; Kuwayama, H; Matsubara, Y; Miyaji, H; Murakami, M; Sanuki, T; Terao, S; Yamazaki, Y; Yoshida, S, 2012) |
| " We aimed to clarify the efficacy of rabeprazole for preventing peptic ulcer, esophagitis, and gastrointestinal symptoms associated with LDA." | 5.16 | Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. ( Azuma, T; Fujisawa, T; Fujita, T; Hayakumo, T; Inokuchi, H; Kawai, T; Kutsumi, H; Kuwayama, H; Matsubara, Y; Miyaji, H; Murakami, M; Sanuki, T; Terao, S; Yamazaki, Y; Yoshida, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, A | 1 |
| Momo, K | 1 |
| Tanaka, K | 1 |
| Uchikura, T | 1 |
| Kiryu, Y | 1 |
| Niiyama, K | 1 |
| Kodaira, N | 1 |
| Matsuzaki, A | 1 |
| Sasaki, T | 1 |
| Hokimoto, S | 1 |
| Mizobe, M | 1 |
| Akasaka, T | 1 |
| Arima, Y | 1 |
| Kaikita, K | 1 |
| Nakagawa, K | 1 |
| Ogawa, H | 1 |
| Sanuki, T | 1 |
| Fujita, T | 1 |
| Kutsumi, H | 1 |
| Hayakumo, T | 1 |
| Yoshida, S | 1 |
| Inokuchi, H | 1 |
| Murakami, M | 1 |
| Matsubara, Y | 1 |
| Kuwayama, H | 1 |
| Kawai, T | 1 |
| Miyaji, H | 1 |
| Fujisawa, T | 1 |
| Terao, S | 1 |
| Yamazaki, Y | 1 |
| Azuma, T | 1 |
| Go, MF | 1 |
| van Rossum, LG | 1 |
| Laheij, RJ | 1 |
| Vlemmix, F | 1 |
| Jansen, JB | 1 |
| Verheugt, FW | 1 |
1 review available for rabeprazole and Cardiovascular Diseases
| Article | Year |
|---|---|
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2002 |
2 trials available for rabeprazole and Cardiovascular Diseases
| Article | Year |
|---|---|
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; | 2012 |
Health-related quality of life in patients with cardiovascular disease--the effect of upper gastrointestinal symptom treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cardiovascular Diseases; | 2004 |
2 other studies available for rabeprazole and Cardiovascular Diseases
| Article | Year |
|---|---|
Identification of the Components of Proton Pump Inhibitors and Potassium-Competitive Acid Blocker That Lead to Cardiovascular Events in Working-Age Individuals: A 12-Month Retrospective Cohort Study Using a Large Claims Database.
Topics: Cardiovascular Diseases; Cytochrome P-450 CYP2C19; Humans; Lansoprazole; Male; Potassium; Proton Pum | 2022 |
Impact of CYP2C19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation.
Topics: Aged; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interact | 2014 |